Page 161 - 南京医科大学自然版
P. 161

第45卷第12期            严舒桐,刘 琪. 机器学习在类风湿性关节炎诊疗及并发症预测中的研究进展[J].
                 2025年12月                    南京医科大学学报(自然科学版),2025,45(12):1834-1844                      ·1843 ·


                    tol,2021,40(6):2211-2219                           network in rheumatoid arthritis based on network pharma⁃
               [44]GENTE K,FEISST M,MARX D,et al. Altered serum me⁃    cology,bioinformatics analysis,and experimental verifica⁃
                    tabolome as an indicator of paraneoplasia or concomitant  tion[J]. Sci Rep,2024,14(1):6291
                    cancer in patients with rheumatic disease[J]. Ann  [57]YE Z,YE B J,MING Z L,et al. Forecasting rheumatoid
                    Rheum Dis,2024,83(8):974-983                       arthritis patient arrivals by including meteorological fac⁃
               [45]CAI Y,DENG L C,YAO J. Analysis and identification of  tors and air pollutants[J]. Sci Rep,2024,14(1):17840
                    ferroptosis ⁃ related diagnostic markers in rheumatoid ar⁃  [58]MENDOZA⁃PINTO C,SÁNCHEZ⁃TECUATL M,BERRA⁃
                    thritis[J]. Ann Med,2024,56(1):2397572             ROMANI R,et al. Machine learning in the prediction of
               [46]ZHOU Y,LI X,NG L,et al. Identification of copper death⁃  treatment response in rheumatoid arthritis:a systematic
                    associated molecular clusters and immunological profiles  review[J]. Semin Arthritis Rheum,2024,68:152501
                    in rheumatoid arthritis[J]. Front Immunol,2023,14:  [59]KALWEIT M,BURDEN A M,BOEDECKER J,et al. Pa⁃
                    1103509                                            tient groups in rheumatoid arthritis identified by deep
               [47]FU W C,WANG T B,LU Y H,et al. The role of lacty⁃    learning respond differently to biologic or targeted synthetic
                    lation in plasma cells and its impact on rheumatoid arthri⁃  DMARDs[J]. PLoS Comput Biol,2023,19(6):e1011073
                    tis pathogenesis:Insights from single⁃cell RNA sequenc⁃  [60]RIVELLESE F,SURACE A E A,GOLDMANN K,et al.
                    ing and machine learning[J]. Front Immunol,2024,15:  Rituximab versus tocilizumab in rheumatoid arthritis:sy⁃
                    1453587                                            novial biopsy ⁃ based biomarker analysis of the phase 4
               [48]YANG F,SHEN J Y,ZHAO Z M,et al. Unveiling the link  R4RA randomized trial[J]. Nat Med,2022,28(6):1256-
                    between lactate metabolism and rheumatoid arthritis  1268
                    through integration of bioinformatics and machine learn⁃  [61]UKALOVIC D,LEEB B F,RINTELEN B,et al. Predic⁃
                    ing[J]. Sci Rep,2024,14(1):9166                    tion of ineffectiveness of biological drugs using machine
               [49]ADAMI G,FASSIO A,ROSSINI M,et al. Machine learn⁃    learning and explainable AI methods:data from the Aus⁃
                    ing to characterize bone biomarkers profile in rheumatoid  trian Biological Registry BioReg[J]. Arthritis Res Ther,
                    arthritis[J]. Front Immunol,2023,14:1291727        2024,26(1):44
               [50]WU X,SHUAI W,CHEN C,et al. Rapid screening for au⁃  [62]HAGEMAN I,MOL F,ATIQI S,et al. Novel DNA methy⁃
                    toimmune diseases using Fourier transform infrared spec⁃  lome biomarkers associated with adalimumab response in
                    troscopy and deep learning algorithms[J]. Front Immu⁃  rheumatoid arthritis patients[J]. Front Immunol,2023,
                    nol,2023,14:1328228                                14:1303231
               [51]LIN C M A,COOLES F A H,ISAACS J D. Precision medi⁃  [63]TAO W Y,CONCEPCION A N,VIANEN M,et al. Mul⁃
                    cine:the precision gap in rheumatic disease[J]. Nat Rev  tiomics and machine learning accurately predict clinical
                    Rheumatol,2022,18(12):725-733                      response to adalimumab and etanercept therapy in pa⁃
               [52]LI G Q,CHEN H Y,SHEN J C,et al. Unveiling new thera⁃  tients with rheumatoid arthritis[J]. Arthritis Rheumatol,
                    peutic horizons in rheumatoid arthritis:an in⁃depth explo⁃  2021,73(2):212-222
                    ration of circular RNAs derived from plasma exosomes[J].  [64]CHEN Y L,WANG Q,LIU H N,et al. The prognostic
                    J Orthop Surg Res,2025,20(1):109                   value of whole⁃genome DNA methylation in response to
               [53]PLANT D,MACIEJEWSKI M,SMITH S,et al. Profiling      leflunomide in patients with rheumatoid arthritis[J].
                    of gene expression biomarkers as a classifier of methotrexate  Front Immunol,2023,14:1173187
                    nonresponse in patients with rheumatoid arthritis[J].  [65]CHANG M J,FENG Q F,HAO J W,et al. Deciphering
                    Arthritis Rheumatol,2019,71(5):678-684             the molecular landscape of rheumatoid arthritis offers new
               [54]DUQUESNE J,BOUGET V,COURNÈDE P H,et al. Ma⁃         insights into the stratified treatment for the condition[J].
                    chine learning identifies a profile of inadequate responder  Front Immunol,2024,15:1391848
                    to methotrexate in rheumatoid arthritis[J]. Rheumatology  [66]BAXTER N B,LIN C H,WALLACE B I,et al. Develop⁃
                   (Oxford),2023,62(7):2402-2409                       ment of a machine learning model to predict the use of
               [55]ZHANG Z Y,YE M T,GE Y S,et al. Eco⁃friendly nano⁃   surgery in patients with rheumatoid arthritis[J]. Arthritis
                    technology in rheumatoid arthritis:ANFIS ⁃ XGBoost en⁃  Care Res(Hoboken),2024,76(5):636-643
                    hanced layered nanomaterials[J]. Environ Res,2024,262  [67]HETLAND M L,STRANGFELD A,BONFANTI G,et al.
                   (Pt 1):119832                                       Machine learning prediction and explanatory models of se⁃
               [56]JIANG J,HUANG M,ZHANG S S,et al. Identification of  rious infections in patients with rheumatoid arthritis treated
                    Hedyotis diffusa Willd⁃specific mRNA⁃miRNA⁃lncRNA  with tofacitinib[J]. Arthritis Res Ther,2024,26(1):153
   156   157   158   159   160   161   162   163   164   165   166